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The reasons for these differences in susceptibility to metabolic and disuse osteoporosis are not fully 62 understood, and could be dependent differences between intramembranous (calvarial) versus 63 endochondral (limb) primary ossification processes. Contrary to this, primary ossification of the lateral 64 aspect of the clavicle is intramembranous, yet it is this aspect that is more prone to osteoporosis 65 compared with the medial endochondral-derived aspect 4 . What is common, however, is that the medial 66 aspect of the clavicle and skull bones contain neural crest-derived cells 5 . Previous studies have also 67 shown differences in proliferation, osteogenic differentiation and response to growth factors between 68 neural crest dual intramembranous-endochondral-derived orofacial and mesodermal endochondral-69 derived appendicular bones 6,7 . Thus differences may not be solely determined by the mechanism of 70 bone formation or turnover per se, but also possibly by differential regulation of bone formation in 71 distinct sites -in this case an intramembranous-derived calvarial bone with a neural crest component 72 compared with an endochondral-derived bone with no neural crest component.
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As well distinct formation processes, numerous studies have also shown physical and functional 74 differences between osteoclasts derived from appendicular and calvarial sites both in vitro and in vivo 75 which could impact on the susceptibility of individual bones to osteoporosis 8-11 . In addition both 76 matrix composition 12,13 and osteocyte morphology 14 have been shown to differ between calvaria and 77 long bones. These differences may be related to features of site-related osteoblastic heterogeneity 78 including sensitivity to PTH 15 as well as induction of osteoclastogenesis and levels of signalling 79 pathway genes involved in osteoclast formation 16 .
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It has become increasingly clear that defined mature cell phenotypes may in fact show much greater 81 diversity than perhaps has been traditionally conceived and understood 17, 18 . In a previous study from 82 our group we investigated differences in global gene expression patterns between adult rodent long 83 bones and skull bones and matched pairs of isolated osteoblasts derived from femurs and calvaria in 84 vitro. In the isolated bone cells we found 246 differentially expressed genes between osteoblasts from 85 these sources 19 . Prominent amongst differentially expressed genes were genes associated with cell 86 embryonic origin such as homeobox containing genes (Hoxa, Hoxb, Hoxc, Hoxd, Shox) and other 87 transcription factors which are thought to act specifically on embryologically distinct bone formation.
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These include Msx-2, Dlx-5 and Cart1 whose disruption in knock out mice specifically affects cranial 89 bone formation and Tbx-3 which specifically affects limb bone formation 19 . Furthermore, in 90 experiments described by Leucht and co-workers, mandibular Hoxa -ve and femoral Hoxa+ve 91 osteogenic stem cells were tested for their ability to contribute to healing in mandibular and femoral 92 bone defects in vivo. They demonstrated that Hoxa +ve cells were unable to contribute to healing in 93 the mandibular site, but Hoxa -ve cells contributed to wound healing in the femoral site 20 . Taken 94 together the data suggest the hypothesis that regionally specific osteoblasts are phenotypically distinct, 95 due to cell autonomous mechanisms. That osteoblasts have "positional memory" such that the 96 localised information they express during embryogenesis persists into the adult organism results in 97 regionally specified differences in osteoblast phenotypes, and further, that these differences translate 98 to functional physiological responses controlling bone homeostasis. Here we studied the phenotypic 99 differences in adult-derived calvarial and femoral osteoblast responses to the induction of 100 osteogenesis, mechanical loading, estrogen, growth factor and cytokine stimulation. Adult derived 101 rodent calvarial cells have reduced proliferation, mineralisation, and growth factor responsiveness 102 when compared to juvenile osteoblasts 21 . Therefore it appears that these altered characteristics make 103 them more suitable to investigate in this context. 
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Despite these previous findings more systematic studies are required to elucidate the differences 111 between mature skull and limb bone derived osteoblasts from to further recognise potential strategies 112 to treat osteoporosis. Therefore, the aim of the study here was to investigate the hypothesis that there 
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Expression of Runx2, osteopontin (Spp1), ALPL and osteocalcin gradually increased during 221 stimulation in both femoral and calvarial cells ( Fig 1A) . No significant differences were observed in 222 the levels of induction of Runx2, ALPL or Spp1 expression between femoral and calvarial cells during 223 stimulation compared to unstimulated cells at any time point. However, osteocalcin expression was 224 increased in femoral compared to calvarial cells (more than 1600 fold higher) at late stages of culture 225 (21D) ( Fig 1A) . As shown in Figure 1A 
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To investigate whether femoral and calvarial cells respond differently to major extracellular stimuli, 253 cells were treated with estrogen (17β-estradiol), Wnt3a, BMP2, FGF-2 or PDGF-BB and the effects on 254 proliferation and ALP activity were assessed. Estrogen had no significant effect on either femoral or 255 calvarial cells ( Fig 3A) . Similarly, we were unable to observe any stimulatory effect in presence of
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A C C E P T E D ACCEPTED MANUSCRIPT 11 BMP2 and Wnt3a ( Fig 3B) . Disparities between our findings and others could be due to culture 257 conditions. Most studies were conducted in presence of osteogenic media or other stimulus in 258 combination with BMP2 or Wnt3a, while we treated the cells in absence of any other factors. On the 259 other hand both FGF-2 and PDGF-BB significantly stimulated calvarial cell proliferation over 260 controls, while only a minor effect was observed on femoral cell proliferation ( Fig 3B) . FGF-2 was 261 significantly inhibitory for ALP activity in both femoral and calvarial cells ( Fig 3B) . Since no 262 significant effect was observed following treatment with estrogen, we further investigated the role of the maturation and mineralisation period ( Fig 4A-B) , whereas expression levels of co-activators cells 285 remained relatively unchanged between femoral and calvarial cells ( Fig 4B) . Interestingly expression 286 of ERα was low at mRNA level and remained at an undetectable level during the course of the study.
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ERß expression was higher in unstimulated femoral compared to calvarial osteoblasts (Fig. 5A ).
288
However, ERß expression was significantly reduced when osteogenesis was induced in both calvarial 289 and femoral cells and remained low to the late stage of mineralisation (21 days) ( Fig 5C) .
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Role of Rerg in femoral and calvarial cells.
292
We also investigated the Ras-related and estrogen-regulated growth-inhibitor (Rerg) which has been 293 suggested as an estrogen responsive gene 26 . Rerg was differentially expressed in calvarial cells 294 compared with femoral cells with basal Rerg expression being 1200 fold greater in calvarial than 295 femoral osteoblasts (Fig 5A-B) . However, upon osteogenic induction Rerg expression was 296 dramatically increased in femoral cells reaching a maximum of 64-fold when compared with 297 unstimulated cells in every line examined ( Fig 5C) . Expression of Rerg in calvarial osteoblasts was 298 reduced following osteogenic stimulation although this was not statistically significant ( Fig 5C) . It is well documented that bones of the skull tend to be resistant to osteoporosis with previous studies 308 investigating differences in characteristics between susceptible long bones and resistant skull bones 309 12,27,28 . However, the idea that this may be due to differences in the action of osteoblasts from these 310 sites has not been extensively investigated. In our previous study we demonstrated that the genes 311 associated with bone mass and mineral density are differentially expressed in functionally distinct 312 skeletal sites 19 . Here, we report that osteoblasts derived from skull and long bones are also 313 functionally distinct. We observed that osteoblasts derived from mature calvariae have a significantly 314 lower ability for accumulation of mineralised matrix compared with femoral osteoblasts when exposed 315 to osteogenic induction medium containing dexamethasone, ascorbic acid and β-glycerophosphate.
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They were unable to produce any mineralisation by 21 days and only negligible amounts by day 45 317 and is consistent with previously observed findings for adult-derived calvarial osteoblasts. Raman 
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Interestingly, in previous work we also found that Rerg was preferentially expressed in calvarial cells 359 in our microarrays 19 . As yet there is no information about the involvement of Rerg in regulating 360 osteoblastic responses to estrogen. Here, using qRT-PCR analysis we showed that basal Rerg 
